{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:34:48Z","timestamp":1781512488502,"version":"3.54.1"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T00:00:00Z","timestamp":1269043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>Dessau RB, Ejlertsen T, Hilden J. Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses. APMIS 2010; 118: 313\u201323.<\/jats:p><jats:p>The laboratory diagnosis of early disseminated Lyme borreliosis (LB) rests on IgM and IgG antibodies in serum. The purpose of this study was to refine the statistical interpretation of IgM and IgG by combining the diagnostic evidence provided by the two immunoglobulins and exploiting the whole range of the quantitative variation in test values. ELISA assays based on purified flagella antigen were performed on sera from 815 healthy Danish blood donors as negative controls and 117 consecutive patients with confirmed neuroborreliosis (NB). A logistic regression model combining the standardized units of the IgM and IgG ELISA assays was constructed and the resulting disease risks graphically evaluated by receiver operating characteristic and \u2018predictiveness\u2019 curves. The combined model improves the discrimination between NB patients and blood donors. Hence, it is possible to report a predicted risk of disease graded for each individual patient, as is theoretically preferable. The predictiveness curve, when adapted to the local pretest probability of LB, allows high\u2010risk and low\u2010risk thresholds to be defined instead of cut\u2010offs based on the laboratory characteristics only, and it allows the extent of under\u2010 and over\u2010treatment to be assessed. It is shown that an example patient with low ELISA results in IgM and IgG, considered negative by the conventional cut\u2010off, has a relatively high risk of belonging to the truly diseased population and a low risk of being false positive. Using a 20% high\u2010risk threshold for advising the clinician to consider treatment, the sensitivity of the assay is increased from 76% to 85%, while the specificity is maintained at around 95%.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2010.02594.x","type":"journal-article","created":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T01:02:06Z","timestamp":1269133326000},"page":"313-323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses"],"prefix":"10.1111","volume":"118","author":[{"given":"RAM B.","family":"DESSAU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOVE","family":"EJLERTSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00d8RGEN","family":"HILDEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,20]]},"reference":[{"key":"e_1_2_5_2_2","unstructured":"European Union Concerted Action on Lyme Borreliosis.http:\/\/meduni09.edis.at\/eucalb\/cms\/index. (accessed on 14 February 2010)."},{"key":"e_1_2_5_3_2","first-page":"2798","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Steere AC","year":"2005"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.484-509.2005"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7043737"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/jcm.29.1.166-173.1991","article-title":"Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu\u2010capture enzyme\u2010linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella","volume":"29","author":"Hansen K","year":"1991","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.26.2.338-346.1988"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/jcm.27.3.545-551.1989","article-title":"Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme\u2010linked immunosorbent assay","volume":"27","author":"Hansen K","year":"1989","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1128\/jcm.28.9.2148-2150.1990","article-title":"Western immunoblot and flagellum enzyme\u2010linked immunosorbent assay for serodiagnosis of Lyme borreliosis","volume":"28","author":"Karlsson M","year":"1990","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300212"},{"key":"e_1_2_5_11_2","first-page":"1","article-title":"Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985\u20131990","volume":"151","author":"Hansen K","year":"1994","journal-title":"Acta Neurol Scand Suppl"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm305"},{"key":"e_1_2_5_13_2","volume-title":"R: A Language and Environment for Statistical Computing"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.2.399"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X070270050101"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00489469"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub2","article-title":"Decision aids for people facing health treatment or screening decisions","author":"O\u2019Connor AM","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200201000-00003"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-5-199803010-00003"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050505"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2010.02594.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2010.02594.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:22:30Z","timestamp":1698747750000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2010.02594.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,20]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1600-0463.2010.02594.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2010.02594.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,20]]},"assertion":[{"value":"2010-03-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}